Effect of rejuvenation hormones on spermatogenesis

Slides:

Advertisements

Similar presentations

Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M

Advertisements

Effects of follicle-stimulating hormone and human chorionic gonadotropin on gonadal steroidogenesis in two siblings with a follicle-stimulating hormone.

Male contraception Fertility and Sterility

Anabolic steroid–induced hypogonadism: diagnosis and treatment

Akanksha Mehta, M.D., Mark Sigman, M.D. Fertility and Sterility

Edward G. Hughes, M.B., F.R.C.S.(C.), Deirdre DeJean, M.Sc.

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.

Michael M. Alper, M.D. Fertility and Sterility

Aromatase, microRNA, and inflammation: a complex relationship

Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Satin S. Patel, M.D., Kelley S. Carrick, M.D., Bruce R. Carr, M.D.

Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy Ewa Nowak-Markwitz,

Medical treatment of ectopic pregnancy: a committee opinion

Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.

Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters Mary K. Samplaski, M.D., Yasir.

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility Alexander M. Quaas, M.D.,

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Oocyte cryopreservation

Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review Seema Menon, M.D., John.

Robert F. Casper, M.D. Fertility and Sterility

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Estrogens and androgens affect human luteal cell function

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for.

Introduction Fertility and Sterility

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Clomiphene citrate at 50: the dawning of assisted reproduction

Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model Robin H. Fogle,

Inequity between male and female coverage in state infertility laws

Treatment of Ovarian Hyperstimulation Syndrome Utilizing a Dopamine Agonist and Gonadotropin Releasing Hormone antagonist N. Rollene, M. Amols, S. Hudson,

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Endometrial morphology and modulation of hormone receptors during ovarian stimulation for assisted reproductive technology cycles Laura Detti, M.D.,

Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis

A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause

David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F

Aviad Cohen, M. D. , Guy Bibi, M. D. , Benny Almog, M. D

P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)

Effectiveness of highly purified human menopausal gonadotropin vs

Diminished paternity and gonadal function with increasing obesity in men Eric M. Pauli, M.D., Richard S. Legro, M.D., Laurence M. Demers, Ph.D., Allen.

Website quality assessment: Mistaking apples for oranges

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization David W. Schmidt, M.D.,,

Fertility and Sterility: an evaluation

Obesity and androgens: facts and perspectives

Paolo Moghetti, M.D. Fertility and Sterility

Upregulation of mRNA expression of vascular endothelial growth factor and its receptors by exogenous human chorionic gonadotropin in cultured oviduct.

Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin β-subunit and pituitary gonadal hormones Daphne.

Current evaluation of amenorrhea

Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist

A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human.

Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility H.-H.

A new era in ovulation induction

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Ahmed Badawy, M.D., Aboubakr.

The gonadotropin-releasing hormone (GnRH)-1 gene, the GnRH receptor gene, and their promoters in patients with idiopathic hypogonadotropic hypogonadism.

Fast action of estrogen on intracellular calcium in dormant mouse blastocyst and its possible mechanism Lin-lin Yu, M.Sc., Jin-hu Zhang, M.B., Ya-ping.

In vitro sildenafil citrate use as a sperm motility stimulant

Angled vas cutter for vasovasostomy: technique and results

Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy Eman A. Elgindy,

The treatment of hypogonadism in men of reproductive age

A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders Hakan Cakmak, M.D., Nam D. Tran,

Endometrial polyps affect uterine receptivity

In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation

Marita Pall, M. D. , Ph. D. , Margaret Nguyen, B. S

Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:

Presentation transcript:

Effect of rejuvenation hormones on spermatogenesis Jared L. Moss, M.D., Lindsey E. Crosnoe, B.S., Edward D. Kim, M.D. Fertility and Sterility Volume 99, Issue 7, Pages 1814-1820 (June 2013) DOI: 10.1016/j.fertnstert.2013.04.003 Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Rejuvenation hormones and mechanism of action. Exogenous testosterone and anabolic androgenic steroids (AAS) negatively affect the hypothalamic-pituitary-gonadal (HPG) axis. Selective estrogen receptor modulators (SERMs) block the negative feedback of estrogen on the HPG axis. Human chorionic gonadotropin (hCG) stimulates Leydig cells. Aromatase inhibitors prevent the conversion of testosterone to estrogen. Fertility and Sterility 2013 99, 1814-1820DOI: (10.1016/j.fertnstert.2013.04.003) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions